AJP - Lung Cellular and Molecular Physiology, Vol 268, Issue 3 532-L538, Copyright © 1995 by American Physiological Society

ARTICLES

Influence of protein kinase C inhibitors on vasoconstrictor responses in the pulmonary vascular bed of cat and rat

A. D. Kaye, B. D. Nossaman, I. N. Ibrahim, C. J. Feng and P. J. Kadowitz
Department of Anesthesiology, Tulane University Medical Center, New Orleans, Louisiana 70112-2699.

The effects of staurosporine and calphostin C, two different protein kinase C (PKC) inhibitors, on pressor responses were studied in the pulmonary vascular bed of the intact chest anesthetized cat and the isolated rat lung. Under conditions of constant lobar blood flow in the cat, injections of the angiotensin peptides, norepinephrine (NE), serotonin, and U-46619 into the lobar arterial perfusion circuit caused dose-related increases in lobar arterial pressure and responses were reproducible with respect to time. Infusion of staurosporine into the perfused lobar artery at 1-2 micrograms/kg for 10 min reduced the pressor response to the angiotensin peptides and to NE; however, staurosporine did not alter pressor responses to serotonin or to the thromboxane mimic U-46619. In a separate series of experiments, the effects of calphostin C were investigated and infusion of the PKC inhibitor into the perfused lobar artery at 1-5 micrograms/kg for 10 min also reduced pressor responses to the angiotensin peptides and to NE and did not alter pressor responses to serotonin or to U-46619. In the isolated rat lung, the inhibitory effects of staurosporine on pulmonary pressor responses were investigated and injections of angiotensin II, NE, and serotonin produced dose-related increases in pulmonary arterial perfusion pressure that were decreased after administration of 20 micrograms ia of the PKC inhibitor staurosporine. (ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				D. S. Damron, N. Kanaya, Y. Homma, S.-O. Kim, and P. A. Murray Role of PKC, tyrosine kinases, and Rho kinase in alpha -adrenoreceptor-mediated PASM contraction Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L1051 - L1064. [Abstract] [Full Text] [PDF]

				B. J. De Witt, A. D. Kaye, I. N. Ibrahim, T. J. Bivalacqua, F. M. D'Souza, R. E. Banister, A. S. Arif, and B. D. Nossaman Effects of PKC isozyme inhibitors on constrictor responses in the feline pulmonary vascular bed Am J Physiol Lung Cell Mol Physiol, January 1, 2001; 280(1): L50 - L57. [Abstract] [Full Text] [PDF]

				K. Zacharowski, A. Olbrich, J. Piper, G. Hafner, K. Kondo, and C. Thiemermann Selective Activation of the Prostanoid EP3 Receptor Reduces Myocardial Infarct Size in Rodents Arterioscler Thromb Vasc Biol, September 1, 1999; 19(9): 2141 - 2147. [Abstract] [Full Text] [PDF]

				J. Bauer, C. Dau, A. Cavarape, F. Schaefer, H. Ehmke, and N. Parekh ANG II- and TxA2-induced mesenteric vasoconstriction in rats is mediated by separate cell signaling pathways Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H1 - H7. [Abstract] [Full Text] [PDF]

				D. S. Damron, H. S. Nadim, S. J. Hong, A. Darvish, and P. A. Murray Intracellular translocation of PKC isoforms in canine pulmonary artery smooth muscle cells by ANG II Am J Physiol Lung Cell Mol Physiol, February 1, 1998; 274(2): L278 - L288. [Abstract] [Full Text] [PDF]